Another question, given that Karl still has full confidence in ARQ, having not sold down his position at all as its share price dived, is whether one should buy ARQ before it reports next week? You would think that any half decent result from ARQ should give a pretty fair boost to both their share price and CDM's.
Ann: Investment Update and NTA January 2019, page-6
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $215.9M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 70.5¢ | 69.5¢ | $126.8K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5497 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.5¢ | 89287 | 2 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| CDM (ASX) Chart |
